纳米医学向瘤向
1Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohyhrid Medical Systems, University Hospital RWTH Aachen, Forckenbeckstrasse 55, 52074, Aachen, Germany.
Advanced materials (Deerfield Beach, Fla.)
|February 16, 2024
概括
纳米药物通过改善药物输送和降低毒性来增强癌症治疗. 克服生物障碍和瘤异质性是这些先进药物配方临床转化的主要挑战.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 纳米药物正在进行癌症治疗的研究,以提高药物输送到瘤的效率,并最大限度地减少健康组织中的积累.
- 超过20种纳米药物配方已被批准用于癌症治疗,还有数百种正在开发中,这突显了该领域的重大进展.
- 尽管取得了进展,但纳米医学瘤向和临床翻译方面的挑战仍然存在,包括材料,生产,生物障碍和病理生理异质性.
研究的目的:
- 审查瘤向纳米医学的原则,进展和产品.
- 识别和讨论阻碍纳米医学翻译的关键问题和挑战.
- 探索未来增强纳米药在癌症治疗中的临床影响的前景.
主要方法:
- 文献综述和对纳米医学癌症治疗当前知识的综合.
- 对现有的纳米医药产品及其临床翻译状态的分析.
- 讨论影响纳米药物疗效的生物学障碍和病理生理因素.
主要成果:
- 纳米药物通过有针对性的输送,在癌症治疗中提高了疗效,降低了毒性.
- 纳米医学转化中的关键瓶包括生物障碍和瘤异质性,超越了材料科学.
- 许多纳米药物配方显示出希望,但临床影响受到了未解决的挑战的限制.
结论:
- 纳米医学通过优化药物输送和安全性概况,为癌症治疗具有显著的潜力.
- 解决生物障碍和瘤异质性对于成功的纳米药物的临床转化至关重要.
- 未来的研究应该专注于克服当前的挑战,以最大限度地发挥纳米医学在瘤学中的临床益处.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


